Clinician attitudes towards cancer treatment guidelines in Australia.

Cancer Evidence based practice Guideline adherence Medical oncology Neoplasms Practice guidelines Radiation oncology Surgical oncology

Journal

BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768

Informations de publication

Date de publication:
16 May 2023
Historique:
received: 09 02 2023
accepted: 09 05 2023
medline: 18 5 2023
pubmed: 17 5 2023
entrez: 16 5 2023
Statut: epublish

Résumé

Clinical Practice Guidelines (CPGs) are designed to guide treatment decisions, yet adherence rates vary widely. To characterise perceived barriers and facilitators to cancer treatment CPG adherence in Australia, and estimate the frequency of previous qualitative research findings, a survey was distributed to Australian oncologists. The sample is described and validated guideline attitude scores reported for different groups. Differences in mean CPG attitude scores across clinician subgroups and associations between frequency of CPG use and clinician characteristics were calculated; with 48 respondents there was limited statistical power to find differences. Younger oncologists (< 50 years) and clinicians participating in three or more Multidisciplinary Team Meetings were more likely to routinely or occasionally use CPGs. Perceived barriers and facilitators were identified. Thematic analysis was conducted on open-text responses. Results were integrated with previous interview findings and presented in a thematic, conceptual matrix. Most barriers and facilitators identified earlier were corroborated by survey results, with minor discordance. Identified barriers and facilitators require further exploration within a larger sample to assess their perceived impact on cancer treatment CPG adherence in Australia, as well as to inform future CPG implementation strategies. This research was Human Research Ethics Committee approved (2019/ETH11722 and 52019568810127, ID:5688).

Identifiants

pubmed: 37194072
doi: 10.1186/s13104-023-06356-5
pii: 10.1186/s13104-023-06356-5
pmc: PMC10188226
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

80

Subventions

Organisme : Australian government Research Training Program Scholarship, Macquarie University
ID : ID:9100002
Organisme : National Health and Medical Research Council Centre for Research Excellence Grant
ID : APP1135048

Informations de copyright

© 2023. The Author(s).

Références

J Eval Clin Pract. 2018 Feb;24(1):135-144
pubmed: 28474459
Value Health. 2011 Sep-Oct;14(6):944-52
pubmed: 21914517
J Clin Epidemiol. 2016 Jan;69:193-8
pubmed: 26327489
BMC Cancer. 2015 Jul 11;15:515
pubmed: 26163015
J Fam Plann Reprod Health Care. 2013 Oct;39(4):281-4
pubmed: 24062499
Am J Infect Control. 2004 Feb;32(1):48-51
pubmed: 14755236
Breast. 2012 Aug;21(4):570-7
pubmed: 22425535
Crit Care Med. 2010 Aug;38(8 Suppl):S282-91
pubmed: 20647785
Gastroenterol Res Pract. 2015;2015:753480
pubmed: 25883645
Radiother Oncol. 2015 Nov;117(2):386-9
pubmed: 26243679
Implement Sci. 2020 May 27;15(1):39
pubmed: 32460797
Asia Pac J Clin Oncol. 2023 Mar 7;:
pubmed: 36881529
Breast. 2010 Oct;19(5):396-401
pubmed: 20452216
Ann Surg Oncol. 2017 Aug;24(8):2080-2088
pubmed: 28547563
Breast. 2010 Oct;19(5):345-9
pubmed: 20223666
J Mix Methods Res. 2009 Jul 1;3(3):208-222
pubmed: 19865603
Eval Health Prof. 2013 Sep;36(3):382-407
pubmed: 23975761
Implement Sci. 2014 Mar 22;9(1):36
pubmed: 24655753
J Eval Clin Pract. 2007 Aug;13(4):607-15
pubmed: 17683303
BMJ Open. 2020 Mar 23;10(3):e035448
pubmed: 32205377
Tech Coloproctol. 2010 Sep;14(3):229-35
pubmed: 20632061
Cancer. 2005 Sep 15;104(6):1129-37
pubmed: 16080176
PLoS One. 2022 Dec 16;17(12):e0279116
pubmed: 36525435
Australas Psychiatry. 2021 Feb;29(1):26-30
pubmed: 33043677
BJU Int. 2016 Apr;117 Suppl 4:35-44
pubmed: 25585989
J Clin Oncol. 2012 Mar 20;30(9):972-9
pubmed: 22355049
Eur Respir J. 2008 Nov;32(5):1141-3
pubmed: 18978131
BMC Health Serv Res. 2007 Jun 14;7:85
pubmed: 17570838
Int J Qual Health Care. 2020 Feb 6;32(Supplement_1):75-83
pubmed: 32026937
CMAJ. 2010 Feb 9;182(2):E78-84
pubmed: 19969563
Breast. 2012 Aug;21(4):562-9
pubmed: 22297168
Am J Med Qual. 2007 May-Jun;22(3):170-6
pubmed: 17485558
J Adv Nurs. 2001 Aug;35(4):521-5
pubmed: 11529951
Qual Health Res. 2006 Mar;16(3):377-94
pubmed: 16449687
Implement Sci. 2017 Jun 5;12(1):74
pubmed: 28583164
Heart Lung. 2007 Jul-Aug;36(4):287-97
pubmed: 17628198
Clin Oncol (R Coll Radiol). 2012 Feb;24(1):e9-17
pubmed: 21802914
Radiother Oncol. 2018 Feb;126(2):191-197
pubmed: 29229506
Cancer Epidemiol. 2015 Aug;39(4):600-11
pubmed: 26004990
Health Serv Res. 2013 Dec;48(6 Pt 2):2134-56
pubmed: 24279835
Med J Aust. 2009 Oct 19;191(8):441-4
pubmed: 19835538
BMJ. 2010 Sep 17;341:c4587
pubmed: 20851841

Auteurs

Mia Bierbaum (M)

Australian Institute of Health Innovation, Macquarie University, Macquarie Park, NSW, 2113, Australia. mia.bierbaum@mq.edu.au.

Gaston Arnolda (G)

Australian Institute of Health Innovation, Macquarie University, Macquarie Park, NSW, 2113, Australia.

Jeffrey Braithwaite (J)

Australian Institute of Health Innovation, Macquarie University, Macquarie Park, NSW, 2113, Australia.

Frances Rapport (F)

Australian Institute of Health Innovation, Macquarie University, Macquarie Park, NSW, 2113, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH